XRP Drops 6% Despite ETF Inclusion; Bull Run Expected Q4 2025

XRP has experienced a significant 6% contraction over the past week, erasing more than $18 billion in market value after failing to breach the critical psychological barrier at $2.80. This bearish performance comes despite the token’s recent inclusion in the groundbreaking Hashdex Nasdaq Crypto Index US ETF, with analysts pointing to Bitcoin’s broader market downturn as the primary catalyst. However, multiple fundamental developments—including Ripple’s banking charter application and pending ETF approvals—suggest the current pessimism may be misplaced, setting the stage for a potential Q4 2025 resurgence.

about XRP Drops 6% Despite ETF Inclusion; Bull Run Expected Q4 2025

BioNexus Adopts Ethereum as Treasury Asset First for Nasdaq-Listed Company

BioNexus Gene Lab has made history as the first Nasdaq-listed company to adopt Ethereum (ETH) as a strategic treasury asset, favoring it over Bitcoin due to its liquidity, utility, and staking rewards. The firm highlighted Ethereum’s leadership in decentralized finance (DeFi) and its robust ecosystem, which is bolstered by growing institutional interest from major players like BlackRock and Fidelity. With the upcoming Pectra upgrade set for April 2025, BioNexus aims to position itself at the forefront of blockchain-integrated corporate finance.

about BioNexus Adopts Ethereum as Treasury Asset First for Nasdaq-Listed Company

Stock Market Faces Uncertainty Ahead of ECB Decision and Jobless Claims Data

The Dow, S&P 500, and Nasdaq are expected to reverse recent gains amid ongoing uncertainty, with key events such as the ECB decision and jobless claims data on the horizon. Intraday data is provided by FACTSET, with historical and current end-of-day data also sourced from them. All quotes reflect local exchange time, and real-time U.S. stock quotes are based on trades reported through Nasdaq, with intraday data delayed by at least 15 minutes or as required by exchanges.

about Stock Market Faces Uncertainty Ahead of ECB Decision and Jobless Claims Data

BioNexus Gene Lab Adopts Ethereum as Primary Treasury Asset

BioNexus Gene Lab has officially adopted Ethereum (ETH) as its primary treasury asset, reflecting a significant shift in corporate financial management. The company released an Ethereum Strategy Whitepaper, emphasizing ETH’s institutional reliability, staking rewards, and scalability. This move aligns with a growing trend of businesses exploring cryptocurrency as a means to enhance their financial reserves amid declining fiat currency value.

about BioNexus Gene Lab Adopts Ethereum as Primary Treasury Asset

Investors Seek Protection Amid Rising Recession Fears and Market Turmoil

As recession fears rise, investors are increasingly seeking crash protection, driving up demand for options tied to the S&P 500. Concerns stem from geopolitical uncertainties, rising tariffs, and strained consumer spending, leading to a significant spike in the CBOE Volatility Index (VIX). With the market experiencing its worst drop since 2008, traders are betting on further declines, reflecting anxiety over potential economic turmoil.

about Investors Seek Protection Amid Rising Recession Fears and Market Turmoil

Alibaba’s Stock Soars After Launching New AI Model and Tariff Relief

Alibaba Group Holding Ltd. (BABA) saw its stock surge by 8.61% after unveiling the QwQ-32B model, which offers DeepSeek-level performance with significantly less data. The company has gained $135 billion in market value this year, buoyed by improving business conditions and support from Beijing.Analysts highlight the positive impact of Alibaba’s advancements in AI on its cloud computing sector, as the firm stabilizes following a government crackdown. Investors are increasingly recognizing the potential of AI to enhance Alibaba’s core business and drive consumption in China.

about Alibaba's Stock Soars After Launching New AI Model and Tariff Relief

BioNexus Becomes First Nasdaq Company to Adopt Ethereum Treasury Strategy

BioNexus Gene Lab Corporation has become the first Nasdaq-listed company to adopt an Ethereum-focused treasury strategy, emphasizing Ethereum’s utility and yield-generation capabilities through staking. The firm released a Whitepaper detailing its rationale for prioritizing Ethereum over Bitcoin, citing its institutional credibility and role in the global financial system. Despite this strategic move, BioNexus faces financial challenges, including a Nasdaq compliance notice and plans for a reverse stock split by April 2025.

about BioNexus Becomes First Nasdaq Company to Adopt Ethereum Treasury Strategy

BioNexus Chooses Ethereum for Treasury Strategy Over Bitcoin

BioNexus Gene Lab has chosen Ethereum over Bitcoin for its treasury strategy, citing Ethereum’s programmability, staking potential, and institutional adoption as key factors. The company aims to be the first Nasdaq-listed firm to adopt an Ethereum-exclusive treasury, leveraging its role in decentralized finance and regulatory support from Wyoming. CEO Sam Tan emphasized Ethereum’s liquidity and stability, positioning BioNexus as a leader in blockchain-integrated corporate finance.

about BioNexus Chooses Ethereum for Treasury Strategy Over Bitcoin

Robinhood Launches Trivia Game Offering Two Million in Crypto Prizes

Robinhood is launching a trivia game in its app, offering over $2 million in Bitcoin and Dogecoin prizes. The contest starts today at 4:45 PM ET, featuring 12 finance and cryptocurrency questions, with $1 million in Bitcoin for those who answer all correctly. An exclusive contest for Robinhood Gold members will follow, providing another $1 million in Bitcoin and additional Dogecoin rewards. Winners will be notified within five days and must claim their prizes within 30 days. In related news, the SEC has concluded its investigation into Robinhood Crypto without pursuing enforcement action, allowing the company to focus on its new initiatives.

about Robinhood Launches Trivia Game Offering Two Million in Crypto Prizes